CDC Presents First State-by-tate Data On Work Limitations Caused By Arthritis
Work limitation due to arthritis in all working-age adults ranges from a low of 3.4 percent in Hawaii to a high of 15 percent in Kentucky, according to a Centers for Disease Control and Prevention (CDC) study that provides the first ever state-by-state data on adults experiencing work limitations caused by arthritis. The proportion of working-age adults with arthritis who reported that the disease was severe enough to limit their ability to work ranged from 25. [click link for full article]
Argenes Initiates Phase I Clinical Study Of ARG098 (Anti-Fas IgM Monoclonal Antibody), A Novel Therapeutics For Rheumatoid Arthritis, In Europe
Tokyo, Japan - Argenes, Inc. announce that it has started Phase I clinical study of the novel anti-rheumatoid arthritis (RA) agent ARG098 in patients with RA in Belgium and has administered to the first patient. The clinical study intends to evaluate the safety and tolerability of ARG098 into the knee joint cavity of patients with RA and examine its efficacy and pharmacokinetics.Efficacy of ARG098 on RA was found in the collaborative study with Santen Pharmaceutical Co., Ltd. [click link for full article]
Heart-Healthy Exercise May Also Be Knee-Healthy Exercise
The world’s most common joint disease, osteoarthritis (OA) is a major cause of disability among adults over the age of 50. Whether physical activity is beneficial or detrimental to weight-bearing joints, knees in particular, has been open to debate. Some studies implicate physical activity in provoking knee OA, while others suggest that physical activity may actually protect the knee joint from the disease. [click link for full article]
